Pharming (PHAR) Inventory (2019 - 2025)

Pharming's Inventory history spans 7 years, with the latest figure at $64.9 million for Q4 2025.

  • Quarterly results put Inventory at $64.9 million for Q4 2025, up 16.47% from a year ago — trailing twelve months through Dec 2025 was $64.9 million (up 16.47% YoY), and the annual figure for FY2025 was $64.9 million, up 16.47%.
  • Inventory for Q4 2025 was $64.9 million at Pharming, up from $55.7 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $64.9 million in Q4 2025 to a low of -$4.3 million in Q4 2023.
  • The 5-year median for Inventory is -$2.0 million (2022), against an average of $22.4 million.
  • The sharpest move saw Inventory tumbled 116.95% in 2023, then skyrocketed 1403.18% in 2024.
  • Year by year, Inventory stood at -$2.4 million in 2021, then increased by 19.49% to -$2.0 million in 2022, then tumbled by 116.95% to -$4.3 million in 2023, then skyrocketed by 1403.18% to $55.7 million in 2024, then rose by 16.47% to $64.9 million in 2025.
  • According to Business Quant data, Inventory over the past three periods came in at $64.9 million, $55.7 million, and -$4.3 million for Q4 2025, Q4 2024, and Q4 2023 respectively.